[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591833":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":26,"centralContacts":10,"locations":30,"responsibleParty":44,"collaborators":10,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":67,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Second Affiliated Hospital of Xi'an Jiaotong University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Exacerbation of erythema following PDT group",null,"Patients experiencing exacerbation of clinical symptoms, such as darker coloration than before treatment, following at least one Hemoporfin-PDT session were recruited.",[13,14],"Combination Product: HMME-PDT","Device: Ultrasound examinations",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"COMBINATION_PRODUCT","HMME-PDT","Prior to treatment, patients or their guardians provided written informed consent. Then patients were then prepared for the procedure by fully exposing the treatment area and shielding the surrounding normal skin with a black cloth. Hemoporfin (Shanghai Fudan-Zhangjiang Bio-Pharmaceutical) was administrated intravenously at a dosage of 5.0 mg\u002Fkg. Subsequently, patients underwent light radiation at 532 nm (Wuhan Yage Optic and Electronic Technique, Wuhan, China) for 18 to 25 minutes, with a power density randing form 75 to 110 mW\u002Fcm2.",[9],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"DEVICE","Ultrasound examinations","Ultrasound examinations were performed using three types of devices: a Paragon XHD equipped with a L38-22 probe operating at a frequency of 20-30 MHz (Kolo Medical Co., Ltd, Suzhou, China), a DUB Skin Scanner with a 22 MHz probe (Taberna Pro Medicum, German), or a Mindray Resona 7 featuring an L14-5WU linear probe set to a frequency range of 11-12 MHz frequency (Mindray Bio-Medical Electronics Co., Ltd, Shenzhen, China).",[9],[27],{"name":28,"affiliation":5,"role":29},"Weihui Zeng","STUDY_CHAIR",[31],{"facility":32,"status":10,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":10},"The Second Affiliated Hospital of Xi'an Jiaotong University","Xi'an","Shaanxi","710004","China","CN",{"type":39,"coordinates":40},"Point",[41,42],108.92861,34.25833,{"lat":42,"lon":41},{"type":45,"investigatorFullName":28,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Professor","100591833","exacerbation-of-erythema-following-pdt-in-patients-with-probable-capillary-malformation-arteriovenous-malformation-syndrome-retrospective-analysis-of-ultrasound-and-clinical-characteristics-100591833",false,"NCT06985563","Exacerbation of Erythema Following PDT in Patients With Probable Capillary Malformation-Arteriovenous Malformation Syndrome: Retrospective Analysis of Ultrasound and Clinical Characteristics.","Inclusion Criteria:\n\n* Patients who were greater than or equal to 1 year old at the time of their first HMME-PDT treatment.\n\n  * Patients who experiencing exacerbation of clinical symptoms, such as darker coloration than before treatment.\n\n    * Patients who have undergone one or more HMME-PDT treatments. ④ Patients with complete basic information and treatment-related information.","ALL","1 Year",{"count":56,"type":57},16,"ACTUAL","OBSERVATIONAL","This study aims to reduce the misdiagnosis rate of PWSs and improve the diagnosis of CM-AVM using ultrasound. Furthermore, we seek to provide more evidence-based recommendations for the treatment of patients with probable CM-AVM syndrome, particularly those presenting with erythema.",[61],"Probable Capillary Malformation-Arteriovenous Malformation Syndrome",[63,64,65,66],"exacerbation of erythema following PDT","probable CM-AVM syndrome","Ultrasound","retrospective study","COMPLETED","2025-05-14",{"date":70,"type":57},"2025-05-22",{"date":72,"type":57},"2024-03-01",{"date":74,"type":57},"2024-06-01",{"name":5,"class":6},1]